Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y

Gene

Volumn 377, Issue 1-2, 2006, Pages 177-185

  Benlhabib, Houda ^a   Herrera, Julio E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

E2F; Stathmin

Indexed keywords

CCAAT BINDING FACTOR; NUCLEAR FACTOR Y; STATHMIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE; CELL GROWTH; CELL NUCLEUS; CELL SYNCHRONIZATION; CONTROLLED STUDY; DATA ANALYSIS; ELECTROPHORETIC MOBILITY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION INITIATION SITE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENES, REPORTER; HUMANS; LUCIFERASES; MICE; MUTAGENESIS, SITE-DIRECTED; NIH 3T3 CELLS; STATHMIN; TRANSFECTION;

EID: 33746146371     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.04.004     Document Type: Article

References (46)

1. Ahn J., Murphy M., Kratowicz S., Wang A., Levine A.J., and George D.L. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 18 (1999) 5954-5958
2. Baldassarre G., et al. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cells 7 (2005) 51-63
3. Bernadt C.T., Nowling T., Wiebe M.S., and Rizzino A. NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner. Gene Expr. 12 (2005) 193-212
4. Boehm M., et al. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21 (2002) 3390-3401
5. Brattsand G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br. J. Cancer 83 (2000) 311-318
6. Brattsand G., et al. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia 7 (1993) 569-579
7. Caretti G., Salsi V., Vecchi C., Imbriano C., and Mantovani R. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 278 (2003) 30435-30440 (Electronic publication 2003 May 27)
8. Chen W., Ji J., Xu X., He S., and Ru B. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosci. 21 (2003) 209-216
9. Curmi P.A., et al. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82 (2000) 142-150
10. Currie R.A. Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J. Biol. Chem. 273 (1998) 18220-18229
11. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
12. Friedrich B., Gronberg H., Landstrom M., Gullberg M., and Bergh A. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate 27 (1995) 102-109
13. Good L.F., and Chen K.Y. Cell cycle- and age-dependent transcriptional regulation of human thymidine kinase gene: the role of NF-Y in the CBP/tk binding complex. Biol. Signals 5 (1996) 163-169
14. Hosoya H., Ishikawa K., Dohi N., and Marunouchi T. Transcriptional and post-transcriptional regulation of pr22 (Op18) with proliferation control. Cell Struct. Funct. 21 (1996) 237-243
15. Huang Y.C., Chen J.Y., and Hung W.C. Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3. Oncogene 23 (2004) 4856-4861
16. Iancu-Rubin C., and Atweh G.F. p27(Kip1) and stathmin share the stage for the first time. Trends Cell Biol. 15 (2005) 346-348
17. Inoue T., Kamiyama J., and Sakai T. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274 (1999) 32309-32317
18. Johnsen J.I., et al. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int. J. Cancer 88 (2000) 685-691
19. Kamiyama J., Inoue T., Ohtani-Fujita N., Minami S., Yamagishi H., and Sakai T. The ubiquitous transcription factor NF-Y positively regulates the transcription of human p27Kip1 through a CCAAT box located in the 5-upstream region of the p27Kip1 gene. FEBS Lett. 455 (1999) 281-285
20. Koppel J., et al. Induction of stathmin expression during liver regeneration. FEBS Lett. 331 (1993) 65-70
21. Luo X.N., Arcasoy M.O., Brickner H.E., Mistry S., Schechter A.D., and Atweh G.F. Regulated expression of p18, a major phosphoprotein of leukemic cells. J. Biol. Chem. 266 (1991) 21004-21010
22. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26 (1998) 1135-1143
23. Mantovani R. The molecular biology of the CCAAT-binding factorNF-Y. Gene 239 (1999) 15-27
24. Mantovani R., Li X.Y., Pessara U., Hooft van Huisjduijnen R., Benoist C., and Mathis D. Dominant negative analogs of NF-YA. J. Biol. Chem. 269 (1994) 20340-20346
25. Melhem R.F., Strahler J.R., Hailat N., Zhu X.X., and Hanash S.M. Involvement of OP18 in cell proliferation. Biochem. Biophys. Res. Commun. 179 (1991) 1649-1655
26. Melhem R.F., Zhu X.X., Hailat N., Strahler J.R., and Hanash S.M. Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J. Biol. Chem. 266 (1991) 17747-17753
27. Mistry S.J., and Atweh G.F. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt. Sinai J. Med. 69 (2002) 299-304
28. Nettelbeck D.M., Jerome V., and Muller R. A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control. Gene Ther. 6 (1999) 1276-1281
29. Ngwenya S., and Safe S. Cell context-dependent differences in the induction of E2F-1 gene expression by 17 beta-estradiol in MCF-7 and ZR-75 cells. Endocrinology 144 (2003) 1675-1685
30. Nicolas M., Noe V., and Ciudad C.J. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F. Biochem. J. 371 (2003) 265-275
31. Osada S., Daimon S., Nishihara T., and Imagawa M. Identification of DNA binding-site preferences for nuclear factor I-A. FEBS Lett. 390 (1996) 44-46
32. Osada S., Yamamoto H., Nishihara T., and Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J. Biol. Chem. 271 (1996) 3891-3896
33. Peng Y., and Jahroudi N. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Blood 99 (2002) 2408-2417
34. Peng Y., and Jahroudi N. The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J. Biol. Chem. 278 (2003) 8385-8394 (Electronic publication 2003 Jan 02)
35. Polager S., and Ginsberg D. E2F mediates sustained G2 arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress. J. Biol. Chem. 278 (2003) 1443-1449 (Electronic publication 2002 Nov 21)
36. Polzin R.G., Benlhabib H., Trepel J., and Herrera J.E. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Gene 341 (2004) 209-218
37. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23 (1995) 4878-4884
38. Roos G., Brattsand G., Landberg G., Marklund U., and Gullberg M. Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7 (1993) 1538-1546
39. Rowlands D.C., Jones N.A., Brown G., Potter M., Muschinski B., and Maclennan I.C. The proliferation-associated cytosolic protein Lap18 (stathmin) is expressed at atypically low levels in BALB/c plasmacytoma cells. Curr. Top. Microbiol. Immunol. 194 (1995) 73-80
40. Rowlands D.C., et al. Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages. Lab. Invest. 72 (1995) 100-113
41. Salsi V., et al. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J. Biol. Chem. 278 (2003) 6642-6650 (Electronic publication 2002 Dec 12)
42. Sorensen P., and Wintersberger E. Sp1 and NF-Y are necessary and sufficient for growth-dependent regulation of the hamster thymidine kinase promoter. J. Biol. Chem. 274 (1999) 30943-30949
43. Steinman R.A., Yaroslavskiy B., Kaplan S.S., Goff J.P., and Shields D.S. Clonal response of K562 leukemic cells to exogenous p21WAF1. Leuk. Res. 24 (2000) 601-610
44. Wang C., et al. Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. J. Biol. Chem. 280 (2005) 12339-12343 (Electronic publication 2005 Feb 14)
45. Xu Y., Banville D., Zhao H.F., Zhao X., and Shen S.H. Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements. Gene 269 (2001) 141-153
46. Zwicker J., et al. Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 23 (1995) 3822-3830